Heterogeneity of high-potency multilineage hematopoietic stem cells and identification of 'Super' transplantability.

IF 23.1 1区 医学 Q1 HEMATOLOGY Blood Pub Date : 2025-04-21 DOI:10.1182/blood.2024027872
Fang Dong,Sen Zhang,Caiying Zhu,Zining Yang,Lisha Wang,Yao Ma,Jiayi Lu,Xialin Li,Xiaofang Wang,Nini Wang,Shanshan Zhang,Miner Xie,Jinhong Wang,Xiaobing Zhang,Yawei Zheng,Shihui Ma,Hideo Ema,Hui Cheng,Sha Hao,Toshio Suda,Yu Lan,Bing Liu,Ping Zhu,Junren Chen,Tao Cheng
{"title":"Heterogeneity of high-potency multilineage hematopoietic stem cells and identification of 'Super' transplantability.","authors":"Fang Dong,Sen Zhang,Caiying Zhu,Zining Yang,Lisha Wang,Yao Ma,Jiayi Lu,Xialin Li,Xiaofang Wang,Nini Wang,Shanshan Zhang,Miner Xie,Jinhong Wang,Xiaobing Zhang,Yawei Zheng,Shihui Ma,Hideo Ema,Hui Cheng,Sha Hao,Toshio Suda,Yu Lan,Bing Liu,Ping Zhu,Junren Chen,Tao Cheng","doi":"10.1182/blood.2024027872","DOIUrl":null,"url":null,"abstract":"Hematopoietic stem cells (HSCs) are heterogeneous, and the quality of HSCs - that is, 'transplantability' - is a key determinant for posttransplant hematopoietic reconstitution. However, molecular modalities of high-potency HSCs with superior transplantability still remain poorly understood. Here, we conducted large-scale single-clone serial-transplant experiments and tracked descendant cells of 288 HSC clones to quantify their intrinsic capability for hematopoietic reconstitution. Using integrated single-cell transcriptional, immunophenotypical, and Bayesian dynamic analyses, we uncovered three classes of HSC clones - 'Super', 'Flash', and 'Trickle' - that had higher output in the 1st generation but exhibited markedly different behavior in later generations. The 'Super'-class HSC clones comprised 4% of the HSCs and manifested persistent superior transplantability and balanced myeloid/lymphoid lineage outputs across generations in serial transplants. The 'Super'-class HSCs had a unique molecular signature, including low expression of CD27, that was distinct from previously known 'Classical HSC' signatures. Validation experiments indicated that CD27- HSCs had superior transplantability compared to CD27+ HSCs. Our study asserted an operational definition for 'Super' transplantability of HSCs, defined its molecular program, and suggested new directions for enriching high-potency HSCs in grafts.","PeriodicalId":9102,"journal":{"name":"Blood","volume":"12 1","pages":""},"PeriodicalIF":23.1000,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1182/blood.2024027872","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Hematopoietic stem cells (HSCs) are heterogeneous, and the quality of HSCs - that is, 'transplantability' - is a key determinant for posttransplant hematopoietic reconstitution. However, molecular modalities of high-potency HSCs with superior transplantability still remain poorly understood. Here, we conducted large-scale single-clone serial-transplant experiments and tracked descendant cells of 288 HSC clones to quantify their intrinsic capability for hematopoietic reconstitution. Using integrated single-cell transcriptional, immunophenotypical, and Bayesian dynamic analyses, we uncovered three classes of HSC clones - 'Super', 'Flash', and 'Trickle' - that had higher output in the 1st generation but exhibited markedly different behavior in later generations. The 'Super'-class HSC clones comprised 4% of the HSCs and manifested persistent superior transplantability and balanced myeloid/lymphoid lineage outputs across generations in serial transplants. The 'Super'-class HSCs had a unique molecular signature, including low expression of CD27, that was distinct from previously known 'Classical HSC' signatures. Validation experiments indicated that CD27- HSCs had superior transplantability compared to CD27+ HSCs. Our study asserted an operational definition for 'Super' transplantability of HSCs, defined its molecular program, and suggested new directions for enriching high-potency HSCs in grafts.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高效多系造血干细胞的异质性和“超级”可移植性鉴定。
造血干细胞(hsc)是异质的,而hsc的质量——即“可移植性”——是移植后造血重建的关键决定因素。然而,具有优越可移植性的高效造血干细胞的分子模式仍然知之甚少。在这里,我们进行了大规模的单克隆连续移植实验,并跟踪288个HSC克隆的后代细胞,以量化其造血重建的内在能力。通过综合单细胞转录、免疫表型和贝叶斯动态分析,我们发现了三种类型的HSC克隆——“超级”、“闪光”和“细流”——它们在第一代中具有较高的产量,但在后代中表现出明显不同的行为。“超级”级HSC克隆占造血干细胞的4%,在连续移植中表现出持续优越的可移植性和平衡的骨髓/淋巴谱系输出。“超级”类HSC具有独特的分子特征,包括CD27的低表达,这与先前已知的“经典HSC”特征不同。验证实验表明,与CD27+造血干细胞相比,CD27-造血干细胞具有更好的可移植性。本研究明确了造血干细胞“超级”可移植性的操作定义,确定了其分子程序,并提出了在移植物中富集高效造血干细胞的新方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Blood
Blood 医学-血液学
CiteScore
23.60
自引率
3.90%
发文量
955
审稿时长
1 months
期刊介绍: Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate.
期刊最新文献
From Breakthroughs to Blueprints: Evolving Evidence and Future Directions in Relapsed and Refractory Large B-Cell Lymphoma. Novel strategies targeting mutant calreticulin in essential thrombocythemia and myelofibrosis. Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3. Platelets in the crossfire of immune checkpoint therapy. Nanotube vesicles: a new neutrophil inflammatory response.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1